CI
CELG

Cavalier Investments’s Celgene Corp CELG Stock Holding History

Cavalier Investments’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,749
Closed -$255K – 182
2017
Q3 		$255K Hold
1,749
– – 0.12% 127
2017
Q2 		$227K Sell
1,749
-386
-18% -$47.3K 0.13% 133
2017
Q1 		$266K Sell
2,135
-173
-7% -$20.7K 0.15% 123
2016
Q4 		$267K Buy
2,308
+75
+3% +$8.35K 0.17% 95
2016
Q3 		$233K Buy
+2,233
New +$242K 0.14% 108
2016
Q1 		– Sell
-1,671
Closed -$200K – 147
2015
Q4 		$200K Buy
+1,671
New +$193K 0.12% 110

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cavalier Investments's CELG Position: Q4 2017 in Review

Cavalier Investments sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,749 shares — an estimated $255K sold.

Cavalier Investments first reported a position in CELG in Q4 2015 and held it in 6 quarters. The position peaked at $267K in Q4 2016. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Cavalier Investments reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Cavalier Investments sold 1,749 Celgene Corp shares in Q4 2017, an estimated $255K.
  • Cavalier Investments first reported a position in Celgene Corp in Q4 2015 and held it in 6 quarters.
  • Cavalier Investments's Celgene Corp position peaked at $267K in Q4 2016.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Cavalier Investments's 13F filing for Q4 2017, filed 13 Feb 2018.